Triple Therapy (LABA-LAMA-Inhaled Corticosteroid) for COPD

Nicholas Salter, MD, MPH

Alexei O. DeCastro, MD

American Family Physician. 2025;111(1):18A-18B.

Author disclosure: No relevant financial relationships.

NICHOLAS SALTER, MD, MPH, and ALEXEI O. DeCASTRO, MD, Department of Family Medicine, Medical University of South Carolina, Charleston

Address correspondence to Nicholas Salter, MD, MPH, at saltern@musc.edu.

Author disclosure: No relevant financial relationships.

1.Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: 2024 report. Accessed December 2, 2024. https://goldcopd.org/2024-gold-report/
2.van Geffen WH, Tan DJ, Walters JA, et al. Inhaled corticosteroids with combination inhaled long-acting beta2-agonists and long-acting muscarinic antagonists for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2023(12):CD011600.

This series is coordinated by Christopher W. Bunt, MD, AFP assistant medical editor, and the NNT Group.

A collection of Medicine by the Numbers published in AFP is available at https:// www.aafp.org/afp/mbtn.